Mark Mattson
Johns Hopkins University School of Medicine
Mark Mattson is a neuroscientist, an adjunct professor of neuroscience at the Johns Hopkins University School of Medicine, and the former chief of the Neuroscience Research Laboratory at the National Institute on Aging. His research focuses on the cellular and molecular effects of dietary restriction, intermittent fasting, and metabolic switching on aging, longevity, and metabolic traits. He also studies mechanisms of neuroprotection, synaptic plasticity, neurogenesis, and the principle of hormesis in brain health.
82 claims checked on air: 4 context 2 contradicted 68 supported 8 unverified
What they said on air - citing their own research
7 citing their own research
Running wheel exercise and environmental enrichment in animals increase the number of mitochondria in nerve cells and synapses in certain brain regions.
"And we find that running wheel exercise, what we call environmental enrichment, where we have the animals in cages where they have essentially like a playground-type environment where they can maintain their mind more active, and under those conditions, exercise, mental exercise, there's an increase in the number of mitochondria in nerve cells, and associated with that, in some—at least in some brain regions—there can even be an increase in the number of synapses between nerve cells" (said at 0:09:08)
Animal and preclinical studies show that aerobic exercise (such as running) and cognitive/environmental enrichment stimulate mitochondrial biogenesis (increasing mitochondrial DNA copy number and key regulatory markers like PGC-1α) and promote synaptic plasticity and synaptogenesis in regions such as the hippocampus and cortex. Because the supporting evidence consists of animal models and narrative neurobiology reviews, the GRADE certainty is rated very low.
- supports: Exercise training increases mitochondrial biogenesis in the brain. (Journal of applied physiology (Bethesda, Md. : 1985) 2011) · cited 351x in the literature
"Exercise training increased PGC-1α, SIRT1, and CS mRNA and mtDNA in most brain regions in addition to the soleus (P < 0.05)... These findings suggest that exercise training increases brain mitochondrial biogenesis" (abstract, results and conclusions)
pubmedfull study (doi) - supports: Activity-dependent, stress-responsive BDNF signaling and the quest for optimal brain healt… (Neuroscience 2013) · cited 181x in the literature
"Optimal brain health throughout the lifespan is promoted by intermittent challenges such as exercise, cognitive stimulation and dietary energy restriction, that subject neurons to activity-related metabolic stress. At the molecular level, such challenges to neurons result in the production of proteins involved in neurogenesis, learning and memory and neuronal survival; examples include proteins that regulate mitochondrial biogenesis" (abstract, passage verified)
pubmedfull study (doi) - supports: Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplas… (Free radical biology & medicine 2017) · cited 269x in the literature
"Very similar to the effects of the stress of exercise on muscle cells, emerging findings suggest that neurons respond to activity by activating signaling pathways (e.g., Ca 2+ , CREB, PGC-1α, NF-κB) that stimulate mitochondrial biogenesis and cellular stress resistance." (abstract, passage verified)
pubmedfull study (doi)
It typically takes at least 10 hours of fasting to deplete liver glycogen stores and initiate the metabolic switch to fat and ketone utilization.
"It typically takes at least 10 hours to deplete the glucose in the liver. So if a person eats breakfast, lunch, and dinner, and then has a snack around 8:00 or 9:00, they may get up and eat breakfast and have not depleted the energy in their liver and have not switched to using fats." (said at 0:13:13)
Established physiological literature confirms that following cessation of food intake, liver glycogen stores are progressively broken down to maintain circulating blood glucose levels. Depletion of hepatic glycogen stores and the subsequent 'metabolic switch'—characterized by increased adipose tissue lipolysis, fatty acid mobilization, hepatic fat oxidation, and ketone production—typically occurs after roughly 10 to 14 hours (or beyond 12 hours) of fasting. Consequently, eating late-evening snacks followed by breakfast without an extended overnight fasting window prevents the full transition to ketone and fat utilization.
- supports: Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of Fasting. (Obesity (Silver Spring, Md.) 2018) · cited 774x in the literature
"This review is focused on the physiological responses of major organ systems, including the musculoskeletal system, to the onset of the metabolic switch: the point of negative energy balance at which liver glycogen stores are depleted and fatty acids are mobilized (typically beyond 12 hours after cessation of food intake). Emerging findings suggest that the metabolic switch from glucose to fatty acid-derived ketones represents an evolutionarily conserved trigger point that shifts metabolism from lipid/cholesterol synthesis and fat storage to mobilization of fat through fatty acid oxidation and fatty acid-derived ketones" (abstract, passage verified)
pubmedfull study (doi)
In animal studies, it takes approximately two weeks of intermittent fasting before measurable changes occur in antioxidant enzyme levels, mitochondrial numbers, synapse counts, and learning and memory.
"one thing we found in pretty much all of our animal studies where we look at the brains, it takes a couple weeks before we see measurable changes in whatever: upregulation of antioxidant enzyme levels, increased number of mitochondria in neurons, increased number of synapses, improvements in learning and memory." (said at 0:24:25)
Preclinical animal research and narrative reviews by Mark Mattson and colleagues demonstrate that bioenergetic challenges such as intermittent fasting trigger neuroplastic adaptations in rodent brains, including upregulation of antioxidant defenses, mitochondrial biogenesis, increased synaptic density, and improved learning and memory. However, the specific time course of approximately two weeks reflects experimental observation periods in rodent fasting protocols (such as alternate-day fasting) rather than an established physiological timeline validated in humans. Because these neurobiological findings derive primarily from animal and mechanistic studies, the certainty of evidence for this specific time-dependent adaptation is very low.
Intermittent fasting increases activity in certain neural networks during the fasting period.
"with intermittent fasting, there is evidence that during the fasting, there's actually some increase, at least in some neural networks, in activity, neural networks." (said at 0:30:36)
Preclinical and human neuroimaging studies demonstrate that intermittent fasting and the resulting metabolic switch to ketone utilization alter brain function, showing enhanced synaptic adaptations and activity across specific neural circuits, including hippocampal networks, hypothalamic pathways, and motor regions.
Mice undergoing treadmill training combined with alternate-day fasting for two months demonstrated statistically significantly superior running endurance compared to mice undergoing treadmill training on a normal diet.
"there was a statistically significantly better endurance in the mice that were on intermittent fasting during the two months of treadmill training." (said at 0:48:18)
A 2018 study led by researchers at the National Institute on Aging (Marosi et al., PMID 29485903) evaluated male mice randomized to either ad libitum feeding or alternate-day food deprivation (ADF) combined with daily treadmill training. After the training period, a run-to-exhaustion test confirmed that mice maintained on alternate-day fasting during treadmill training exhibited significantly superior running endurance compared to mice fed ad libitum during training. Because the available evidence derives exclusively from an animal model, the certainty of evidence is very low.
Treadmill exercise in alternate-day fasted mice increased blood ketone levels nearly twice as much as fasting alone.
"And they measured ketones, which were elevated with intermittent fasting, and the exercise increased the ketone levels much more, almost twice as much, by the—you know, when you take their blood after the end of the treadmill training." (said at 0:49:18)
A 2018 animal study by Marosi et al. evaluated male mice on alternate-day food deprivation (ADF) combined with daily treadmill endurance training for one month. Metabolomic and physiological analyses showed that alternate-day fasting triggered ketosis, and post-exercise measurements showed that treadmill running further potentiated this metabolic switch and circulating ketone metabolite levels compared to fasting alone.
Combining alternate-day fasting with treadmill exercise produces a greater increase in soleus muscle mitochondria count in mice than either intervention alone.
"they took out muscle cells from the soleus muscle, which is an endurance muscle in the leg of the mice, and they did some measurements that suggested that intermittent fasting and the exercise increased the number of mitochondria in the muscle cells, and that the increase was the most when you have the combination of the intermittent fasting and the exercise." (said at 0:49:18)
A preclinical study in male mice by Marosi et al. (2018) examined the effects of alternate-day food deprivation (ADF), daily treadmill exercise, or their combination. Analysis of soleus muscle and liver gene expression showed that intermittent fasting combined with treadmill training potentiated molecular pathways involved in mitochondrial biogenesis and metabolism more than diet or exercise alone. Because this evidence comes entirely from an animal experiment, the certainty of evidence for human outcomes is very low.
Fact-checked episodes
Publications
- Dietary restriction in aging and longevity.Nature aging 2026 · CEBM Level 5
- Uncovering shared and tissue-specific molecular adaptations to intermittent fasting in liver, brain, and muscle.eLife 2026 · CEBM Level 5
- Corrigendum to "Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid β-peptide and the membrane lipid peroxidation product 4-hydroxynonenal" [Experimental Neurology, vol. 213,1 (2008): 114-21].Experimental neurology 2026 · CEBM Level 5
- Impact of Parental Time-Restricted Feeding on Offspring Metabolic Phenotypic Traits.International journal of biological sciences 2025 · CEBM Level 5
- The cyclic metabolic switching theory of intermittent fasting.Nature metabolism 2025 · CEBM Level 5
- Author Correction: Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets.Nature medicine 2025 · CEBM Level 5
- The hormesis principle of neuroplasticity and neuroprotection.Cell metabolism 2024 · CEBM Level 5
- Tdrd3-null mice show post-transcriptional and behavioral impairments associated with neurogenesis and synaptic plasticity.Progress in neurobiology 2024 · CEBM Level 5
- A Dynamical Systems View of Psychiatric Disorders-Theory: A Review.JAMA psychiatry 2024 · CEBM Level 5
- A Dynamical Systems View of Psychiatric Disorders-Practical Implications: A Review.JAMA psychiatry 2024 · CEBM Level 5
- Common and divergent molecular mechanisms of fasting and ketogenic diets.Trends in endocrinology and metabolism: TEM 2024 · CEBM Level 5
- Brain responses to intermittent fasting and the healthy living diet in older adults.Cell metabolism 2024 · CEBM Level 2
- Brain responses to intermittent fasting and the healthy living diet in older adults.Cell metabolism 2024 · CEBM Level 2
- International consensus on fasting terminology.Cell metabolism 2024 · CEBM Level 5
- Time-Restricted Feeding Reduces Atherosclerosis in LDLR KO Mice but Not in ApoE Knockout Mice.Arteriosclerosis, thrombosis, and vascular biology 2024 · CEBM Level 5
- Akt-activated GSK3β inhibitory peptide effectively blocks tau hyperphosphorylation.Archives of pharmacal research 2024 · CEBM Level 5
- The catabolic - anabolic cycling hormesis model of health and resilience.Ageing research reviews 2024 · CEBM Level 5
- Soy peptide as an anecdote to undernutrition.Life metabolism 2024 · CEBM Level 5
- Mitochondrial SIRT3 Deficiency Results in Neuronal Network Hyperexcitability, Accelerates Age-Related Aβ Pathology, and Renders Neurons Vulnerable to Aβ Toxicity.Neuromolecular medicine 2023 · CEBM Level 5
- The potential of gene editing for Huntington's disease.Trends in neurosciences 2023 · CEBM Level 5
- Tdrd3-null mice show post-transcriptional and behavioral impairments associated with neurogenesis and synaptic plasticity.Research square 2023 · CEBM Level 5
- Author Correction: How does hormesis impact biology, toxicology, and medicine?npj aging 2023 · CEBM Level 5
- Multiomics analyses reveal dynamic bioenergetic pathways and functional remodeling of the heart during intermittent fasting.eLife 2023 · CEBM Level 5
- Transcriptional changes in the rat brain induced by repetitive transcranial magnetic stimulation.Frontiers in human neuroscience 2023 · CEBM Level 5
- When a Calorie Is Not a Calorie: Metabolic and Molecular Effects of Intermittent Fasting in Humans; Exploratory Outcomes of a Randomized Clinical Trial.Aging biology 2023 · CEBM Level 2
- Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer.British journal of cancer 2022 · CEBM Level 2
- TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration.Nature neuroscience 2022 · CEBM Level 5
- Integrative epigenomic and transcriptomic analyses reveal metabolic switching by intermittent fasting in brain.GeroScience 2022 · CEBM Level 5
- NADPH and Mitochondrial Quality Control as Targets for a Circadian-Based Fasting and Exercise Therapy for the Treatment of Parkinson's Disease.Cells 2022 · CEBM Level 5
- Neuronal Aquaporin 1 Inhibits Amyloidogenesis by Suppressing the Interaction Between Beta-Secretase and Amyloid Precursor Protein.The journals of gerontology. Series A, Biological sciences and medical sciences 2021 · CEBM Level 5
- Age-related impairment of cerebral blood flow response to K ATP channel opener in Alzheimer's disease mice with presenilin-1 mutation.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2021 · CEBM Level 5
- Mitochondrial DNA in extracellular vesicles declines with age.Aging cell 2021 · CEBM Level 3
- Applying available knowledge and resources to alleviate familial and sporadic neurodegenerative disorders.Progress in molecular biology and translational science 2021 · CEBM Level 5
- NAD + supplementation prevents STING-induced senescence in ataxia telangiectasia by improving mitophagy.Aging cell 2021 · CEBM Level 5
- Neuronal and Astrocytic Extracellular Vesicle Biomarkers in Blood Reflect Brain Pathology in Mouse Models of Alzheimer's Disease.Cells 2021 · CEBM Level 5
- Glucose metabolic crosstalk and regulation in brain function and diseases.Progress in neurobiology 2021 · CEBM Level 5
- NAD + supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING.Proceedings of the National Academy of Sciences of the United States of America 2021 · CEBM Level 5
- Alzheimer's disease-causing presenilin-1 mutations have deleterious effects on mitochondrial function.Theranostics 2021 · CEBM Level 5
- Intermittent and periodic fasting, longevity and disease.Nature aging 2021 · CEBM Level 5
- A mitochondrial uncoupler prodrug protects dopaminergic neurons and improves functional outcome in a mouse model of Parkinson's disease.Neurobiology of aging 2020 · CEBM Level 5
- SIRT3 Haploinsufficiency Aggravates Loss of GABAergic Interneurons and Neuronal Network Hyperexcitability in an Alzheimer's Disease Model.The Journal of neuroscience : the official journal of the Society for Neuroscience 2020 · CEBM Level 5
- Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease. A systematic review and meta-analysis of human studies.Ageing research reviews 2020 · CEBM Level 1
- Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.Neurobiology of disease 2020 · CEBM Level 5
- Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunction.Acta neuropathologica 2020 · CEBM Level 5
- Effects of Intermittent Fasting on Health, Aging, and Disease. Reply.The New England journal of medicine 2020 · CEBM Level 5
- Topoisomerase 3β knockout mice show transcriptional and behavioural impairments associated with neurogenesis and synaptic plasticity.Nature communications 2020 · CEBM Level 5
- Publisher Correction: Intermittent metabolic switching, neuroplasticity and brain health.Nature reviews. Neuroscience 2020 · CEBM Level 5
- Astrocyte- and Neuron-Derived Extracellular Vesicles from Alzheimer's Disease Patients Effect Complement-Mediated Neurotoxicity.Cells 2020 · CEBM Level 5
- Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing.Nature reviews. Drug discovery 2020 · CEBM Level 5
- Involvement of GABAergic interneuron dysfunction and neuronal network hyperexcitability in Alzheimer's disease: Amelioration by metabolic switching.International review of neurobiology 2020 · CEBM Level 5
- Preface.International review of neurobiology 2020 · CEBM Level 5
- Hormesis: A potential strategic approach to the treatment of neurodegenerative disease.International review of neurobiology 2020 · CEBM Level 5
- Preface.International review of neurobiology 2020 · CEBM Level 5
- Impact of Coffee and Cacao Purine Metabolites on Neuroplasticity and Neurodegenerative Disease.Neurochemical research 2019 · CEBM Level 5
- Activity-dependent neuronal Klotho enhances astrocytic aerobic glycolysis.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2019 · CEBM Level 5
- Calcium dysregulation mediates mitochondrial and neurite outgrowth abnormalities in SOD2 deficient embryonic cerebral cortical neurons.Cell death and differentiation 2019 · CEBM Level 5
- Uric acid enhances longevity and endurance and protects the brain against ischemia.Neurobiology of aging 2019 · CEBM Level 5
- An Evolutionary Perspective on Why Food Overconsumption Impairs Cognition.Trends in cognitive sciences 2019 · CEBM Level 5
- Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease.Nature neuroscience 2019 · CEBM Level 5
- Assessment of NAD + metabolism in human cell cultures, erythrocytes, cerebrospinal fluid and primate skeletal muscle.Analytical biochemistry 2019 · CEBM Level 5
- Sonic hedgehog expression in the postnatal brain.Biology open 2019 · CEBM Level 5
- Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model.Nature neuroscience 2019 · CEBM Level 5
- SIRT3 mediates hippocampal synaptic adaptations to intermittent fasting and ameliorates deficits in APP mutant mice.Nature communications 2019 · CEBM Level 5
- Curcumin and hormesis with particular emphasis on neural cells.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2019 · CEBM Level 5
- Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice.Neuromolecular medicine 2019 · CEBM Level 5
- NRF2/ARE pathway negatively regulates BACE1 expression and ameliorates cognitive deficits in mouse Alzheimer's models.Proceedings of the National Academy of Sciences of the United States of America 2019 · CEBM Level 5
- Sideroflexin 3 is a Mitochondrial Protein Enriched in Neurons.Neuromolecular medicine 2019 · CEBM Level 5
- A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.Biological psychiatry 2019 · CEBM Level 5
- Comparing 3D ultrastructure of presynaptic and postsynaptic mitochondria.Biology open 2019 · CEBM Level 5
- Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.ACS pharmacology & translational science 2019 · CEBM Level 5
- Intergenerational Metabolic Syndrome and Neuronal Network Hyperexcitability in Autism.Trends in neurosciences 2019 · CEBM Level 5
- A Pilot Study of Exenatide Actions in Alzheimer's Disease.Current Alzheimer research 2019 · CEBM Level 2
- NAD + in Brain Aging and Neurodegenerative Disorders.Cell metabolism 2019 · CEBM Level 5
- NAD + augmentation restores mitophagy and limits accelerated aging in Werner syndrome.Nature communications 2019 · CEBM Level 5
- Effects of Intermittent Fasting on Health, Aging, and Disease.The New England journal of medicine 2019 · CEBM Level 5
- Intercellular transfer of pathogenic α-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal.Neurobiology of aging 2018 · CEBM Level 5
- Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of Fasting.Obesity (Silver Spring, Md.) 2018 · CEBM Level 5
- Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases.Cell death and differentiation 2018 · CEBM Level 5
- Combination Therapy with Low-Dose IVIG and a C1-esterase Inhibitor Ameliorates Brain Damage and Functional Deficits in Experimental Ischemic Stroke.Neuromolecular medicine 2018 · CEBM Level 5
- Intermittent metabolic switching, neuroplasticity and brain health.Nature reviews. Neuroscience 2018 · CEBM Level 5
- NAD + supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency.Proceedings of the National Academy of Sciences of the United States of America 2018 · CEBM Level 5
- Transcriptome analysis reveals intermittent fasting-induced genetic changes in ischemic stroke.Human molecular genetics 2018 · CEBM Level 5
- Metabolic and molecular framework for the enhancement of endurance by intermittent food deprivation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2018 · CEBM Level 5
- Deficiency of Toll-like receptors 2, 3 or 4 extends life expectancy in Huntington's disease mice.Heliyon 2018 · CEBM Level 5
- Notch signaling and neuronal death in stroke.Progress in neurobiology 2018 · CEBM Level 5
- Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid β-peptide levels, without discernable behavioral effects in an APP/PS1 mutant transgenic mouse model of Alzheimer's disease.Neurobiology of aging 2018 · CEBM Level 5
- Invaginating Structures in Mammalian Synapses.Frontiers in synaptic neuroscience 2018 · CEBM Level 5
- Transcriptome analysis reveals intermittent fasting-induced genetic changes in ischemic stroke.Human molecular genetics 2018 · CEBM Level 5
- Mice lacking the transcriptional regulator Bhlhe40 have enhanced neuronal excitability and impaired synaptic plasticity in the hippocampus.PloS one 2018 · CEBM Level 5
- Altered Extracellular Vesicle Concentration, Cargo, and Function in Diabetes.Diabetes 2018 · CEBM Level 3
- Effect of intermittent vs. daily calorie restriction on changes in weight and patient-reported outcomes in people with multiple sclerosis.Multiple sclerosis and related disorders 2018 · CEBM Level 2
- Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States.Cell metabolism 2018 · CEBM Level 5
- Brain regional synchronous activity predicts tauopathy in 3×TgAD mice.Neurobiology of aging 2018 · CEBM Level 5
- Enhancing and Extending Biological Performance and Resilience.Dose-response : a publication of International Hormesis Society 2018 · CEBM Level 5
- Hydroxyurea attenuates oxidative, metabolic, and excitotoxic stress in rat hippocampal neurons and improves spatial memory in a mouse model of Alzheimer's disease.Neurobiology of aging 2018 · CEBM Level 5
- Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance.Free radical biology & medicine 2017 · CEBM Level 5
- Sonic hedgehog pathway activation increases mitochondrial abundance and activity in hippocampal neurons.Molecular biology of the cell 2017 · CEBM Level 5
- Early involvement of lysosome dysfunction in the degeneration of cerebral cortical neurons caused by the lipid peroxidation product 4-hydroxynonenal.Journal of neurochemistry 2017 · CEBM Level 5
- Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease.Journal of neurochemistry 2017 · CEBM Level 5
- TNF-α Differentially Regulates Synaptic Plasticity in the Hippocampus and Spinal Cord by Microglia-Dependent Mechanisms after Peripheral Nerve Injury.The Journal of neuroscience : the official journal of the Society for Neuroscience 2017 · CEBM Level 5
- Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms.Trends in neurosciences 2017 · CEBM Level 5
- Whole-Body Vibration Mimics the Metabolic Effects of Exercise in Male Leptin Receptor-Deficient Mice.Endocrinology 2017 · CEBM Level 5
- Exercise and BDNF reduce Aβ production by enhancing α-secretase processing of APP.Journal of neurochemistry 2017 · CEBM Level 5
- Tomatidine enhances lifespan and healthspan in C. elegans through mitophagy induction via the SKN-1/Nrf2 pathway.Scientific reports 2017 · CEBM Level 5
- Brain metabolism in health, aging, and neurodegeneration.The EMBO journal 2017 · CEBM Level 5
- skn-1 is required for interneuron sensory integration and foraging behavior in Caenorhabditis elegans.PloS one 2017 · CEBM Level 5
- Age-Related Changes in Plasma Extracellular Vesicle Characteristics and Internalization by Leukocytes.Scientific reports 2017 · CEBM Level 3
- Toll-like receptor 4 mediates fat, sugar, and umami taste preference and food intake and body weight regulation.Obesity (Silver Spring, Md.) 2017 · CEBM Level 5
- Invaginating Presynaptic Terminals in Neuromuscular Junctions, Photoreceptor Terminals, and Other Synapses of Animals.Neuromolecular medicine 2017 · CEBM Level 5
- Walking speed decline in older adults is associated with elevated pro-BDNF in plasma extracellular vesicles.Experimental gerontology 2017 · CEBM Level 3
- Age-associated alterations in the levels of cytotoxic lipid molecular species and oxidative stress in the murine thymus are reduced by growth hormone treatment.Mechanisms of ageing and development 2017 · CEBM Level 5
- Purine Biosynthesis Enzymes in Hippocampal Neurons.Neuromolecular medicine 2017 · CEBM Level 5
- NAD + in Aging: Molecular Mechanisms and Translational Implications.Trends in molecular medicine 2017 · CEBM Level 5
- In a randomized trial in prostate cancer patients, dietary protein restriction modifies markers of leptin and insulin signaling in plasma extracellular vesicles.Aging cell 2017 · CEBM Level 2
- Cognitive and behavioral evaluation of nutritional interventions in rodent models of brain aging and dementia.Clinical interventions in aging 2017 · CEBM Level 5
- How does hormesis impact biology, toxicology, and medicine?NPJ aging and mechanisms of disease 2017 · CEBM Level 5
- Mitochondria in hippocampal presynaptic and postsynaptic compartments differ in size as well as intensity.Matters 2017 · CEBM Level 5
- Sonic Hedgehog Signaling and Hippocampal Neuroplasticity.Trends in neurosciences 2016 · CEBM Level 5
- Extracellular Vesicle-Associated Aβ Mediates Trans-Neuronal Bioenergetic and Ca 2+ -Handling Deficits in Alzheimer's Disease Models.NPJ aging and mechanisms of disease 2016 · CEBM Level 5